American International Group, Inc. Cti Biopharma Corp Transaction History

American International Group, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$4.2 - $6.01 $4,040 - $5,781	962 Added 2.03%	48,327 $202,000
Q4 2022 Feb 10, 2023	SELL	$4.45 - $6.17 $765 - $1,061	-172 Reduced 0.36%	47,365 $284,000
Q3 2022 Nov 14, 2022	BUY	$5.36 - $7.43 $22,426 - $31,087	4,184 Added 9.65%	47,537 $277,000
Q2 2022 Aug 12, 2022	BUY	$3.55 - $6.27 $153,903 - $271,823	43,353 New	43,353 $259,000
Q2 2019 Aug 13, 2019	SELL	$0.8 - $1.03 $26,059 - $33,551	-32,574 Closed	0 $0
Q1 2019 May 06, 2019	SELL	$0.9 - $1.37 $951 - $1,448	-1,057 Reduced 3.14%	32,574 $32,000
Q4 2018 Feb 13, 2019	SELL	$0.73 - $2.19 $188 - $565	-258 Reduced 0.76%	33,631 $25,000
Q3 2018 Nov 09, 2018	BUY	$1.72 - $5.24 $1,050 - $3,201	611 Added 1.84%	33,889 $73,000
Q2 2018 Aug 08, 2018	BUY	$3.81 - $5.26 $126,789 - $175,042	33,278 New	33,278 $166,000

Ticker CTIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 114,385,000
Market Cap $1.04B
Description
CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients w...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.